Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2022 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#1406 Collision Tumor of the Appendix: Mucinous Cystadenoma and Carcinoid. A Case Report

Introduction: Mucinous cystadenoma is the most common of benign neoplasms of the appendix and carcinoid is the most common type of primary malignant lesions of the appendix.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: OConnor J

Authors: Pombo T, O'Connor J, Dominichini E, Belli S, Pesce V,

Keywords: collision tumor, appendix tumor,

#938 Clinical Characteristics of 144 patients (pts) Included in a Multidisciplinary Group, with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) G2 (WHO 2010). Grupo Argentum.

Introduction: Neuroendocrine tumors (NETs) G2 of the digestive tract are a heterogeneous group of tumors. Several treatment options including chemotherapy and target therapy are used, but there is a lack of prospective trials assessing the role of predictive factors in this population.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: OConnor J

Authors: O'Connor J, Pesce V, Bestanti C, Marmissolle F, Price P,

Keywords: neuroendocrine tumor, G2, survival,

#328 Report of Two First-Degree Relatives with Appendix Carcinoid and Review of the Literature

Introduction: Appendix endocrine tumors have an incidence of 2-3 patient/millon/year. They are more common in women, diagnosed incidentally during appendectomies.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: OConnor J, Pesce V, Bestani C, Cabanne A, Domenichini E,

Keywords: well-differentiated endocrine tumors of appendix, endocrine tumor of the appendix ,

#141 Incidence of second primary tumors in patients with neuroendocrine tumors

Introduction: Based on epidemiological data from SEER 1950-1999, 22.4% cases of non-carcinoid second primary tumors have been described in patients diagnosed with neuroendocrine tumors. The incidence of this type of tumors varies, depending on the series assessed.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Pesce V, OConnor J, Mendez G, Bestani C, Marmisolle F,

Keywords: neuroendocrine tumor, second primary tumors,

Abstract Submissions in 2023

Abstract submissions for 2023 will open in September 2022!

 

The 20th Annual ENETS Conference in 2023 will provide the principal platform for NET researchers around the world to present their latest findings. ENETS will select the best abstracts submitted in both clinical and basic science and present these in sessions within the framework of its scientific programme.

 

Participants of the ENETS Conferences in 2022 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.